News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
807,382 Results
Type
Article (73804)
Company Profile (698)
Press Release (732880)
Section
Business (227197)
Career Advice (3708)
Deals (39266)
Drug Delivery (122)
Drug Development (89159)
Employer Resources (194)
FDA (17768)
Job Trends (17089)
News (387196)
Policy (38672)
Tag
Academia (2974)
Alliances (55793)
Alzheimer's disease (1398)
Approvals (17701)
Artificial intelligence (193)
Bankruptcy (394)
Best Places to Work (12598)
Biotechnology (478)
Breast cancer (219)
Cancer (1643)
Cardiovascular disease (141)
Career advice (3154)
Cell therapy (353)
Clinical research (71082)
Collaboration (620)
Compensation (319)
COVID-19 (2823)
C-suite (147)
Data (1513)
Diabetes (210)
Diagnostics (6742)
Earnings (92215)
Employer resources (167)
Events (126633)
Executive appointments (513)
FDA (18589)
Funding (549)
Gene therapy (247)
GLP-1 (746)
Government (5012)
Healthcare (20784)
Infectious disease (2930)
Inflammatory bowel disease (129)
Interviews (722)
IPO (17622)
Job creations (4984)
Job search strategy (2588)
Layoffs (501)
Legal (9865)
Lung cancer (246)
Manufacturing (244)
Medical device (14466)
Medtech (14471)
Mergers & acquisitions (21891)
Metabolic disorders (574)
Neuroscience (1802)
NextGen: Class of 2025 (7626)
Non-profit (5071)
Northern California (1921)
Obesity (327)
Opinion (253)
Patents (144)
People (63369)
Pharmaceutical (143)
Phase I (21954)
Phase II (31006)
Phase III (23373)
Pipeline (638)
Postmarket research (3254)
Preclinical (9654)
Radiopharmaceuticals (261)
Rare diseases (320)
Real estate (7130)
Regulatory (25533)
Research institute (2644)
Resumes & cover letters (579)
Southern California (1672)
Startups (4187)
United States (17882)
Vaccines (685)
Weight loss (253)
Date
Today (150)
Last 7 days (448)
Last 30 days (2109)
Last 365 days (37539)
2025 (1883)
2024 (37951)
2023 (42568)
2022 (53926)
2021 (58723)
2020 (57667)
2019 (51305)
2018 (39085)
2017 (36830)
2016 (37739)
2015 (43730)
2014 (38413)
2013 (34388)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1185)
Arizona (218)
Asia (48159)
Australia (8278)
California (4490)
Canada (1585)
China (382)
Colorado (203)
Connecticut (229)
Europe (108550)
Florida (624)
Georgia (158)
Illinois (483)
Indiana (263)
Maryland (748)
Massachusetts (3571)
Michigan (206)
Minnesota (343)
New Jersey (1251)
New York (1253)
North Carolina (926)
Northern California (1921)
Ohio (165)
Pennsylvania (1032)
South America (1561)
Southern California (1672)
Texas (662)
Utah (128)
Washington State (467)
807,382 Results for "sumitomo pharmaceuticals co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
1 of 80,739
Next
